DR. ANTHONY JOHN DISTASIO II, M.D.

NORFOLK, VA

Research Active
Orthopaedic Surgery - Orthopaedic Trauma NPI registered 21+ years 8 publications 2014 – 2025 NPI: 1831195353
MiceMice, Inbred C57BLMutationDisease Models, AnimalSignal TransductionPhenotypeNeural CrestGTP-Binding ProteinsEmbryonic DevelopmentHigh-Throughput Screening AssaysMesodermMutagenesisSkullEthylnitrosoureaWnt1 Protein

Practice Location

600 GRESHAM DR STE 204
NORFOLK, VA 23507-1904

Phone: (757) 388-5680

What does ANTHONY DISTASIO research?

Dr. Distasio primarily studies genetic factors affecting brain and facial development, specifically conditions like primary microcephaly and craniofacial birth defects. He has conducted significant research on how specific genes influence brain structure and cell health, showing a direct connection between genetic mutations and severe health implications. Additionally, he has worked on improving clinical trial methodologies for patients suffering from brain hemorrhages, emphasizing the importance of teamwork and communication among medical professionals to enhance treatment options.

Key findings

  • In a study on primary microcephaly, Dr. Distasio found that mutations in the Copb2 gene lead to severe health issues in embryonic mice, causing them to die within a week of birth.
  • His research on the genetic deficiency disrupting brain development showed significant changes in cell behavior, linking this deficiency to primary microcephaly and raising awareness for early diagnosis and potential treatments.
  • In the BEACH clinical trial for brain hemorrhages, effective communication among doctors increased patient enrollment success, directly contributing to high safety standards and better treatment outcomes.

Frequently asked questions

Does Dr. Distasio study brain hemorrhages?
Yes, he focuses on improving treatments for brain hemorrhages through clinical trials and research.
What conditions are linked to Dr. Distasio's research?
He studies conditions like primary microcephaly, craniofacial birth defects, and kidney disease related to podocyte damage.
What treatments has Dr. Distasio researched?
His research includes the use of the drug everolimus for stabilizing kidney cells, enhancing understanding of genetic disorders, and improving clinical trial methods for better patient outcomes.
Is Dr. Distasio's work relevant to patients with craniofacial anomalies?
Yes, his research on genetic causes of craniofacial birth defects directly benefits these patients and their families.
How does Dr. Distasio's work impact patients with primary microcephaly?
His findings on genetic mutations related to primary microcephaly help improve diagnosis and potential treatments for affected individuals.

Publications in plain English

deficiency disrupts the centrosome-check point in the brain and causes primary microcephaly.

2025

medRxiv : the preprint server for health sciences

Rushforth R, Shamseldin HE, Costantino N, Michaels JR, Sawyer SL +8 more

Plain English
This research focused on a genetic deficiency that disrupts brain development and leads to primary microcephaly, a condition where babies are born with abnormally small brains. The study found that this deficiency affects brain cells in mice, leading to severe microcephaly and other growth issues, with specific changes in cell behavior observed. Understanding this genetic cause is important because it can help identify affected individuals and improve diagnoses and potential treatments for the condition. Who this helps: Patients with primary microcephaly and their families.

PubMed

Operationalizing a complex acute clinical trial: Lessons from the BEACH study.

2025

medRxiv : the preprint server for health sciences

Sorensen G, Remillard W, Schlechter M, Kampp M, Sansing LH +8 more

Plain English
This study focused on how a team at Yale effectively conducted a complex clinical trial for patients with brain hemorrhages. They successfully enrolled patients by improving communication and workflows among doctors, nurses, and researchers, which helped streamline the process. By enhancing these practices, they aim to not only improve trial efficiency but also develop better treatment options for this serious condition. Who this helps: This research benefits patients suffering from brain hemorrhages and their healthcare providers.

PubMed

Operationalizing a complex acute clinical trial: Lessons from the BEACH study.

2025

Journal of clinical and translational science

Sorensen G, Remillard W, Schlechter M, Kampp M, Whisler Brady C +10 more

Plain English
This research paper discusses how Yale University School of Medicine successfully conducted the BEACH clinical trial, which studies treatments for brain hemorrhages. The team faced several challenges and found that effective collaboration among different medical experts was key to enrolling patients successfully and maintaining high safety standards. Their experience highlights the importance of teamwork in medical research, as it can lead to better treatment methods and improved results for patients experiencing such emergencies. Who this helps: This helps patients with brain hemorrhages and the doctors treating them.

PubMed

Nubp2 is required for cranial neural crest survival in the mouse.

2020

Developmental biology

DiStasio A, Paulding D, Chaturvedi P, Stottmann RW

Plain English
This study focused on a specific gene called Nubp2 and its role in the survival of certain cells in developing mouse embryos, particularly those involved in forming the face and skull. Researchers found that when Nubp2 is not functioning, it leads to severe facial deformities and increased cell death during development. This is important because understanding how Nubp2 affects cell survival can help uncover reasons behind certain birth defects and guide future treatments. Who this helps: This helps researchers and doctors working with patients who have craniofacial birth defects.

PubMed

Using human sequencing to guide craniofacial research.

2019

Genesis (New York, N.Y. : 2000)

Liegel RP, Finnerty E, Blizzard L, DiStasio A, Hufnagel RB +4 more

Plain English
This research looked at how genetics can help us understand birth defects that affect the face and skull. The scientists studied a family with a specific genetic syndrome and discovered a variant in the AMOTL1 gene that seems to play a role in this condition. They found that while normal mice survive after birth, those with the same genetic variant identified in the family had a much higher death rate, although the exact reason for this is still unclear. This research matters because it can lead to better understanding and treatment of craniofacial disorders. Who this helps: Patients with craniofacial anomalies and their families.

PubMed

Copb2 is essential for embryogenesis and hypomorphic mutations cause human microcephaly.

2017

Human molecular genetics

DiStasio A, Driver A, Sund K, Donlin M, Muraleedharan RM +7 more

Plain English
The study looked at a gene called Copb2, which is important for brain development, particularly in embryos. Researchers found that mutations in this gene are linked to primary microcephaly, a condition where babies are born with smaller heads and often have intellectual disabilities. In experiments with mice, those with mutations similar to those found in two affected children had severe health problems and died within a week of birth, showing that Copb2 is crucial for proper brain formation. Who this helps: This research benefits patients with primary microcephaly and their families by improving understanding of the condition.

PubMed

Everolimus Stabilizes Podocyte Microtubules via Enhancing TUBB2B and DCDC2 Expression.

2015

PloS one

Jeruschke S, Jeruschke K, DiStasio A, Karaterzi S, Büscher AK +6 more

Plain English
This research studied how the drug everolimus affects special kidney cells called podocytes, which are crucial for filtering blood. The scientists found that everolimus helps stabilize the structure of these cells by increasing the levels of two important proteins, TUBB2B and DCDC2, aiding their function after injury. This stability is vital because damaged podocytes can lead to kidney disease, making everolimus potentially beneficial for maintaining kidney health. Who this helps: This helps patients with kidney issues, especially those at risk of podocyte damage.

PubMed

A gene expression atlas of early craniofacial development.

2014

Developmental biology

Brunskill EW, Potter AS, Distasio A, Dexheimer P, Plassard A +2 more

Plain English
This study looked at how certain genes are expressed during the early development of facial features in mice. Researchers used advanced techniques to analyze cells at different stages of development (specifically at E8.5, E9.5, and E10.5) and found important details about the genetic activity in cells that contribute to forming the face. The findings, which include identifying specific gene interactions crucial for face formation, can help scientists understand facial development better and potentially lead to new insights into facial deformities. Who this helps: This helps researchers and medical professionals working on congenital facial disorders.

PubMed

Frequent Co-Authors

Rolf W Stottmann Gracey Sorensen Will Remillard Maia Schlechter Michael Kampp Cailin Whisler Brady Wendy Ziai Jing Lu Lauren H Sansing Jessica Magid-Bernstein

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.